Preclinical Development of a Vectorized Artificial miRNA Gene Therapy for Tauopathies
Irvin T. Garza, Brina Snyder, Sydni K. Holmes, Katherine M. Pearce, K. L. Knight, Rachel M. Bailey
This paper develops a gene therapy using artificial miRNA delivered via adeno-associated virus to reduce tau in a mouse model of tauopathy, showing efficacy even at late disease stages.
bioRxiv · Oct 12, 2025 · PreprintNeuroscience